All News

US adults show an increase in recreational activity post-COVID-19, but lingering cardiovascular risks from infection highlight the need for ongoing health vigilance.

The study highlights disparities in COVID-19 vaccine access, revealing urban pharmacies excel while rural areas face significant challenges, urging policy changes for equity.

With disease cases increasing substantially between 2012 and 2024, higher-valent vaccines are necessary to protect against nonvaccine serotypes and invasive pneumococcal disease.

Due to the lived realities and trajectory of risk throughout their lifetime, researchers believe women require novel approaches in their cardiovascular health care needs.

Researchers explore highly engaged social media posts related to glucagon-like peptide-1 receptor agonists, attention deficit/hyperactivity disorder stimulants, and autoimmune biologics.

This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.

A study shows dupilumab significantly improves symptoms of allergic fungal rhinosinusitis, offering hope for effective treatment options.

The event will explore the importance of advocacy, gathering experts all across community pharmacy to discuss improving patient access and education.

With evidence of antiobesity properties in human trials, berberine could be an OTC phytotherapeutic option for weight loss.

Investigators analyze COVID-19 positivity trends in New York City, revealing disparities among children and racial groups during the Omicron variant surge.

Study findings highlight the need for further exploration into the racial and ethnic trends of pneumococcal vaccination rates.

Eloralintide shows promising weight loss results in a phase 2 trial, offering a new option for obesity management with improved tolerability.

In patients with diabetes and various levels of UACR, researchers aimed to uncover both the relative and absolute effects of SGLT2 inhibitors.

A study explored how SGLT2 inhibitors impact the kidney, specifically whether effects varied by estimated glomerular filtration rate (eGFR) or albuminuria.

A secondary analysis of the obesity-fertility lifestyle intervention program explored how it impacted the behavior of women with obesity and subfertility.

The NCPDP gathered essential members from the pharmacy community in a roundtable discussion on electronic prior authorizations.

Living in West Virginia for over a decade, Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his experience as a practicing pharmacist amid the US opioid crisis.

Oral semaglutide 25 mg shows significant benefits in weight loss and cardiovascular health for patients with obesity, enhancing overall well-being.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his pain management expertise and discusses current developments in the US opioid epidemic.

Researchers investigate women’s experiences in accessing either prescription or OTC contraceptives.

Finerenone shows promise in reducing kidney damage for type 1 diabetes patients, marking a significant advancement in chronic kidney disease treatment.

To optimize vaccine strategies among young people with Down syndrome, researchers explore the prevalence of adequate immune responses following pneumococcal vaccination.

Older adults with dementia face significantly higher COVID-19 risks, highlighting the need for targeted health strategies during pandemics.

FDA approves lumateperone as an adjunct therapy for major depressive disorder, offering new treatment options for this indication.

A study reveals tailored glucose monitoring intervals for type 2 diabetes patients based on HbA1c levels, enhancing long-term management strategies.

Experts discuss the implications of the Most Favored Nation drug policy, discussing its impact on pricing, community pharmacy, and patient safety in the final part of a webinar series.

Due to humans’ physiologically premature nature, researchers explore maternal psychological distress and childhood neurodevelopment.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.